Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBailey, Nola-
dc.contributor.authorBowden, Patrick-
dc.identifier.citationJournal of Medical Imaging and Radiation Oncology. Conference Publication: (var. pagings). 58 (pp 177), 2014.en_US
dc.description.abstractSBRT aims to deliver an ablative dose of radiotherapy to target tissues, minimising dose to adjacent healthy structures. Oligometastasis describes an intermediate disease state involving five or fewer metastases. Local control (LC) rates of 90% for PCa bony and lymph node metastases treated with SBRT are reported in the literature. This study aims to evaluate the effectiveness of SBRT for PCa oligometastases, assessing improvements in LC, reduction of prostate-specific antigen (PSA) and disease progression.en_US
dc.subjectEpworth Radiation Oncology, Epworth HealthCare, Richmond, Victoria, Australiaen_US
dc.subjectRadiotherapy, Targeteden_US
dc.subjectTargeted Radiotherapyen_US
dc.subjectProstate Canceren_US
dc.subjectCancer of the Prostateen_US
dc.subjectProstate-Specific Antigenen_US
dc.subjectRadiation Oncologyen_US
dc.subjectOncology, Radiationen_US
dc.subjectRadiology, Therapeuticen_US
dc.subjectTherapeutic Radiologyen_US
dc.subjectDisease Progressionen_US
dc.subjectStereotactic Body Radiotherapyen_US
dc.titleThe role of stereotactic body radiotherapy (SBRT) in the treatment of oligometastatic prostate cancer (PCa)-Initial experiences at Epworth Radiation Oncology (ERO).en_US
dc.typeConference Paperen_US
dc.description.conferencename2014 Combined Scientific Meeting: Imaging and Radiation in Personalised Medicineen_US
dc.description.conferencelocationMelbourne, Victoria, Australiaen_US
Appears in Collections:Cancer Services
Epworth Prostate Centre
Radiation Oncology

Files in This Item:
File Description SizeFormat  
p 177 The role of SBRT in the treatment of oligometastatic PCa.pdf229.62 kBAdobe PDFView/Open

Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.